CDCA Co-occurring Disorders & Dual Diagnosis Flashcards
6 cards from real CDCA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 CDCA Co-occurring Disorders & Dual Diagnosis flashcards as text
The ASAM (American Society of Addiction Medicine) criteria assess which dimension related to co-occurring disorders?
Answer: Emotional, behavioral, or cognitive conditions and complications (Dimension 3)
ASAM Dimension 3 specifically evaluates emotional, behavioral, and cognitive conditions and complications, including co-occurring mental health disorders, to guide appropriate level of care placement.
A client reports using alcohol heavily to 'calm down' social anxiety before gatherings. This is an example of:
Answer: Self-medication of an anxiety disorder with alcohol, a common pattern in co-occurring disorders
Using alcohol to manage social anxiety symptoms exemplifies the self-medication pattern seen in co-occurring anxiety and alcohol use disorders.
Which of the following statements about substance-induced disorders is MOST accurate?
Answer: Substance-induced disorders (e.g., substance-induced depression) typically resolve within days to weeks of abstinence
Substance-induced mood and anxiety disorders typically remit within days to weeks of sustained abstinence, unlike independent psychiatric disorders that persist beyond the period of intoxication/withdrawal.
In integrated dual diagnosis treatment, the CDCA's role in addressing a client's mental health symptoms is to:
Answer: Provide supportive counseling, monitor symptoms, collaborate with mental health providers, and facilitate appropriate referrals under supervision
CDCAs support integrated care by monitoring and communicating about mental health symptoms and coordinating with the broader treatment team, within their scope of practice.
Attention-Deficit/Hyperactivity Disorder (ADHD) co-occurring with substance use disorder presents a treatment challenge because:
Answer: Some ADHD medications have abuse potential, requiring careful monitoring and collaboration with prescribers
Stimulant medications used for ADHD have abuse potential, so CDCAs and treatment teams must monitor for misuse while ensuring the client receives appropriate psychiatric care.
When a client with co-occurring disorders relapses, the CDCA should respond by:
Answer: Exploring the relapse as a learning opportunity, assessing safety, and adjusting the treatment plan to address contributing factors
Relapse is understood as a common part of the recovery process, especially with co-occurring disorders, and should prompt a compassionate clinical review rather than punitive responses.